


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.43%
-6.89%
+4.47%
-2.84%
DRTS
Alpha Tau Medical
$3.92
DRTS Price Performance
$3.87 (+1.29%)
$3.85 (+1.82%)
$3.06 (+28.10%)
$3.13 (+25.24%)
DRTS has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

DRTS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
DRTS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
DRTS Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is DRTS current stock price?
What are DRTS stock strengths?
What is DRTS Risk Level?
What is DRTS market cap and volume?
What is DRTS current Stock IQ?
Should I buy DRTS stock right now?
Is DRTS a Strong Buy right now?
What does a 'Strong Buy' rating mean for DRTS?
What does a 'Strong Sell' rating mean for DRTS?
What factors influence DRTS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.43%
-6.89%
+4.47%
-2.84%
DRTS
Alpha Tau Medical
Current Price
$3.92

DRTS Price Performance
$3.87 (+1.29%)
$3.85 (+1.82%)
$3.06 (+28.10%)
$3.13 (+25.24%)
DRTS Analysts Opinion
DRTS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
DRTS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
DRTS Street Sentiment is extremely bullish and have negative views on the near-term outlook
DRTS has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
DRTS Stock IQ
DRTS Latest Analysis
Alpha Tau to Participate in December Investor Conferences. JERUSALEM Dec. 01 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Alpha Tau or the Company) (NASDAQ: DRTS DRTSW) the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® today announced that CFO Raphi Levy will present in the following investor conferences in December 2025.
Mon Dec 1, 2025
ORMP: Advancing Clinical Activities Generating Gains From Investment Portfolio New Rights Plan Adopted. By Trial will focus on key patient subpopulations that have responded to ORMD-0801 following analysis of earlier trial dataOramed Pharmaceuticals (NASDAQ:ORMP) is leveraging its balance sheet to make investments in multiple early stage companies while concurrently advancing its strategy to move its assets forward. Oramed plans to continue its oral insulin development program independently whic
Mon Nov 24, 2025
Alpha Tau Eyes Year-End Japanese Clearance For Alpha DaRT Treatment In Recurrent Head & Neck Cancer . (RTTNews) - Alpha Tau Medical Ltd. (DRTS) a clinical-stage oncology company pioneering Alpha DaRT for solid tumors has several key milestones approaching in the next few months.
Fri Nov 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
DRTS Stock trends
DRTS Stock performance
DRTS Stock analysis
DRTS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.